Riesgo cardiovascular y prescripción farmacológica en pacientes pluripatológicos
Nieves Ramírez‐Duque(Hospital Universitario Virgen del Rocío), Carolina Luque-Amado(Hospital Universitario Virgen Macarena), Máximo Bernabeu‐Wittel(Instituto de Salud Carlos III), Virginia Rodríguez-Martínez, Maria Dolores Nieto‐Martín(Unidad de Investigación en cuidados y servicios de salud (Investén-isciii)), Alberto Escalera-Zalvide(Hospital Juan Ramón Jiménez), Lourdes Moreno-Gaviño(Vall d'Hebron Hospital Universitari), A. Mora-Rufete, José Barbé Gil-Ortega(Vall d'Hebron Hospital Universitari), María Sánchez Ledesma(Complejo Hospitalario de Salamanca)
Cited by 3
Related Papers
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
|European Respiratory Journal|2014|178
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021
|Emerging infectious diseases|2023|81
Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score
|The American Journal of Medicine|2009|52
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
|Journal of Cellular and Molecular Medicine|2008|51
Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study
|BMC Cardiovascular Disorders|2009|34